Cas:62006-34-2 5-methyl-6-(methylamino)-1H-pyrimidin-2-one manufacturer & supplier

We serve Chemical Name:5-methyl-6-(methylamino)-1H-pyrimidin-2-one CAS:62006-34-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-methyl-6-(methylamino)-1H-pyrimidin-2-one

Chemical Name:5-methyl-6-(methylamino)-1H-pyrimidin-2-one
CAS.NO:62006-34-2
Synonyms:2(1H)-Pyrimidinone,5-methyl-4-(methylamino);N4-methyl-5-methylcytosine;5-methyl-4-methylamino-1H-pyrimidin-2-one
Molecular Formula:C6H9N3O
Molecular Weight:139.15500
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.27000
Exact Mass:139.07500
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2(1H)-Pyrimidinone,5-methyl-4-(methylamino) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-methyl-4-methylamino-1H-pyrimidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2(1H)-Pyrimidinone,5-methyl-4-(methylamino) Use and application,5-methyl-4-methylamino-1H-pyrimidin-2-one technical grade,usp/ep/jp grade.


Related News: but are not expected to recover the costs of developing and marketing a treatment drug.” Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process. methyl 2-(5-((tert-butoxycarbonyl)amino)isothiazol-3-yl)-4-oxobutanoate manufacturers The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required. 1-(5-aminopentyl)-3-(2-((5-bromopyridin-2-yl)(3,4-dichlorobenzyl)amino)ethyl)thiourea suppliers The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required. 4′,5′-Dihydro-5′-methyl-furano(2′.3′:2.1)xanthon vendor & factory “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. ,The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required.